Suven Life Sciences Ltd. Financials: Quarterly Results
Revenue
5.58
Cr.
PAT
-101.92
Cr.
EBITDA
-101.92
Cr.
Suven Life Sciences Ltd. Q2FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2.81 | 0.92 | 1.87 | 1.47 | 1.61 |
| Total Income From Operations (Cr.) | 2.81 | 0.92 | 1.87 | 1.47 | 1.61 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | -101.92 | -77.31 | -51.52 | -43.94 | -39.11 |
| P/L Before Exceptional Items & Tax (Cr.) | -101.92 | -77.31 | -51.52 | -43.94 | -39.12 |
| P/L After Tax from Ordinary Activities (Cr.) | -101.92 | -77.31 | -51.52 | -43.94 | -39.12 |
| Net Profit/Loss For the Period (Cr.) | -101.92 | -77.31 | -51.52 | -43.94 | -39.12 |
| Basic EPS | -4.55 | -3.48 | -2.36 | -2.02 | -1.79 |
FAQs
Suven Life Sciences Ltd. announced its quarterly results for Q2 FY2026 on November 11, 2025.
In Q2 FY2026, Suven Life Sciences Ltd. are as follows:
Revenue: ₹5.58 crore
Net Profit: ₹-101.92 crore.
For Q2 FY2026, Suven Life Sciences Ltd. posted ₹5.58 crore in revenue and ₹-101.92 crore in net profit.
Past quarterly results for Suven Life Sciences Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.